LIPOCINE INC NEW
LPCN·53630X203·US·Common Stock·Healthcare - Biotechnology-13D/G
LPCN (LIPOCINE INC NEW) is held by 25 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.6M), BlackRock, Inc. ($713,283), GEODE CAPITAL MANAGEMENT, LLC ($504,741). Net institutional sentiment: Bullish.
25
Holders
Avg rating(5 Elite)
$5.1M
Total Value
68% (26)
Fund Consensus
17 buying - 8 selling
Who's Trading
ActivistIKIkarian Capital, LLC6.3%May 15, 2026
ActivistSMSquadron Master Fund LP6.2%May 15, 2026
InsiderHWHiguchi John W.Buy $81KApr 7, 2026
InsiderHWHiguchi John W.Buy $252KApr 6, 2026
InsiderPVPatel Mahesh V.Buy $51KApr 6, 2026
InsiderPVPatel Mahesh V.Buy $51KApr 2, 2026
13F: Insider & Congress:
Showing 1-20 of 26
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer